Skip to Content

WATSON 835 3.75 (Clorazepate 3.75 mg)

Pill with imprint WATSON 835 3.75 is Blue, Five-sided and has been identified as Clorazepate dipotassium 3.75 mg. It is supplied by Watson Laboratories, Inc..

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 835 3.75

Clorazepate dipotassium

Imprint:
WATSON 835 3.75
Strength:
3.75 mg
Color:
Blue
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
Benzodiazepines
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
52544-0835

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide